Mycobacterium tuberculosis... Can we beat it? Report from a Euroscicon Conference 2013

References

• Bhakta S. An Integration of Interdisciplinary Translational Research in Anti-TB Drug Discovery: Out of the University Research Laboratories to Combat Mycobacterium tuberculosis. Mol Biol 2013; 2:e108; http://dx.doi.org/10.4172/2168-9547.1000e108
   Google Scholar
• Health Protection Agency. HIV in the United Kingdom: 2011 Report. London: Health Protection Services, Colindale. November 2011. London.
   Google Scholar
• Tuberculosis in the UK: 2011 report. London: Health Protection Agency, December 2011.
   Google Scholar
• Global tuberculosis report 2012. Geneva: World Health Organisation, 2012.
   Google Scholar
• Gupta A, Kaul A, Tsolaki AG, Kishore U, Bhakta S. Mycobacterium tuberculosis: immune evasion, latency and reactivation. Immunobiology 2012; 217:363 - 74; http://dx.doi.org/10.1016/j.imbio.2011.07.008; PMID: 21813205
   PubMed Web of Science ®Google Scholar
• Zumla A, Raviglione M, Hafner R, von Reyn CF. Tuberculosis. N Engl J Med 2013; 368:745 - 55; http://dx.doi.org/10.1056/NEJMra1200894; PMID: 23425167
   PubMed Web of Science ®Google Scholar
• Tufariello JM, Chan J, Flynn JL. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis 2003; 3:578 - 90; http://dx.doi.org/10.1016/S1473-3099(03)00741-2; PMID: 12954564
   PubMed Web of Science ®Google Scholar
• Keep NH, Ward JM, Cohen-Gonsaud M, Henderson B. Wake up! Peptidoglycan lysis and bacterial non-growth states. Trends Microbiol 2006; 14:271 - 6; http://dx.doi.org/10.1016/j.tim.2006.04.003; PMID: 16675219
   PubMed Web of Science ®Google Scholar
• Lee E, Holzman RS. Evolution and current use of the tuberculin test. Clin Infect Dis 2002; 34:365 - 70; http://dx.doi.org/10.1086/338149; PMID: 11774084
   PubMed Web of Science ®Google Scholar
• Franco-Paredes C, Rouphael N, del Rio C, Santos-Preciado JI. Vaccination strategies to prevent tuberculosis in the new millennium: from BCG to new vaccine candidates. Int J Infect Dis 2006; 10:93 - 102; http://dx.doi.org/10.1016/j.ijid.2005.06.002; PMID: 16377228
   PubMed Web of Science ®Google Scholar
• Abubakar I, Zignol M, Falzon D, Raviglione M, Ditiu L, Masham S, et al. Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis 2013; 13:529 - 39; http://dx.doi.org/10.1016/S1473-3099(13)70030-6; PMID: 23531391
   PubMed Web of Science ®Google Scholar
• Lawn SD, Mwaba P, Bates M, Piatek A, Alexander H, Marais BJ, et al. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis 2013; 13:349 - 61; http://dx.doi.org/10.1016/S1473-3099(13)70008-2; PMID: 23531388
   PubMed Web of Science ®Google Scholar
• Kaal E, Kolk AHJ, Kuijper S, Janssen H-G. A fast method for the identification of Mycobacterium tuberculosis in sputum and cultures based on thermally assisted hydrolysis and methylation followed by gas chromatography-mass spectrometry. J Chromatogr A 2009; 1216:6319 - 25; http://dx.doi.org/10.1016/j.chroma.2009.06.078; PMID: 19631943
   PubMed Web of Science ®Google Scholar
• Denkinger CM, Grenier J, Stratis AK, Akkihal A, Pant-Pai N, Pai M. Mobile health to improve tuberculosis care and control: a call worth making [Review article]. Int J Tuberc Lung Dis 2013; 17:719 - 27; http://dx.doi.org/10.5588/ijtld.12.0638; PMID: 23541232
   PubMed Web of Science ®Google Scholar
• Christensen H, Garton NJ, Horobin RW, Minnikin DE, Barer MR. Lipid domains of mycobacteria studied with fluorescent molecular probes. Mol Microbiol 1999; 31:1561 - 72; http://dx.doi.org/10.1046/j.1365-2958.1999.01304.x; PMID: 10200973
   PubMed Web of Science ®Google Scholar
• Garton NJ, Waddell SJ, Sherratt AL, Lee S-M, Smith RJ, Senner C, et al. Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum. PLoS Med 2008; 5:e75; http://dx.doi.org/10.1371/journal.pmed.0050075; PMID: 18384229
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection–United States, 2010. MMWR Morb Mortal Wkly Rep 2010; 59:RR-5 1 - 28; PMID: 20075837
   PubMedGoogle Scholar
• Collins L, Franzblau SG. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother 1997; 41:1004 - 9; PMID: 9145860
   PubMed Web of Science ®Google Scholar
• Gupta A, Bhakta S, Kundu S, Gupta M, Srivastava BS, Srivastava R. Fast-growing, non-infectious and intracellularly surviving drug-resistant Mycobacterium aurum: a model for high-throughput antituberculosis drug screening. J Antimicrob Chemother 2009; 64:774 - 81; http://dx.doi.org/10.1093/jac/dkp279; PMID: 19656786
   PubMed Web of Science ®Google Scholar
• Evangelopoulos D, Bhakta S. Rapid Methods for Testing Inhibitors of Mycobacterial Growth. In: Gillespie SH, McHugh TD, eds. Antibiotic Resistance Protocols: Humana Press, 2010:193-201.
   Google Scholar
• Gupta A, Bhakta S. An integrated surrogate model for screening of drugs against Mycobacterium tuberculosis. J Antimicrob Chemother 2012; 67:1380 - 91; http://dx.doi.org/10.1093/jac/dks056; PMID: 22398649
   PubMed Web of Science ®Google Scholar
• Guzman JD, Evangelopoulos D, Gupta A, Birchall K, Mwaigwisya S, Saxty B, et al. Discovery of the anti-tubercular specific activity of ibuprofen and other 2 arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay. BMJ Open 2013; 3:e002672; http://dx.doi.org/10.1136/bmjopen-2013-002672; PMID: 23794563
   PubMedGoogle Scholar
• Guzman JD, Gupta A, Evangelopoulos D, Basavannacharya C, Pabon LC, Plazas EA, et al. Anti-tubercular screening of natural products from Colombian plants: 3-methoxynordomesticine, an inhibitor of MurE ligase of Mycobacterium tuberculosis. J Antimicrob Chemother 2010; 65:2101 - 7; http://dx.doi.org/10.1093/jac/dkq313; PMID: 20719764
   PubMed Web of Science ®Google Scholar
• Basavannacharya C, Moody PR, Munshi T, Cronin N, Keep NH, Bhakta S. Essential residues for the enzyme activity of ATP-dependent MurE ligase from Mycobacterium tuberculosis. Protein Cell 2010; 1:1011 - 22; http://dx.doi.org/10.1007/s13238-010-0132-9; PMID: 21153518
   PubMed Web of Science ®Google Scholar
• Basavannacharya C, Robertson G, Munshi T, Keep NH, Bhakta S. ATP-dependent MurE ligase in Mycobacterium tuberculosis: biochemical and structural characterisation. Tuberculosis (Edinb) 2010; 90:16 - 24; http://dx.doi.org/10.1016/j.tube.2009.10.007; PMID: 19945347
   PubMed Web of Science ®Google Scholar
• Guzman JD, Wube A, Evangelopoulos D, Gupta A, Hüfner A, Basavannacharya C, et al. Interaction of N-methyl-2-alkenyl-4-quinolones with ATP-dependent MurE ligase of Mycobacterium tuberculosis: antibacterial activity, molecular docking and inhibition kinetics. J Antimicrob Chemother 2011; 66:1766 - 72; http://dx.doi.org/10.1093/jac/dkr203; PMID: 21622974
   PubMed Web of Science ®Google Scholar
• Osman K, Evangelopoulos D, Basavannacharya C, Gupta A, McHugh TD, Bhakta S, et al. An antibacterial from Hypericum acmosepalum inhibits ATP-dependent MurE ligase from Mycobacterium tuberculosis. Int J Antimicrob Agents 2012; 39:124 - 9; http://dx.doi.org/10.1016/j.ijantimicag.2011.09.018; PMID: 22079533
   PubMed Web of Science ®Google Scholar
• Munshi T, Gupta A, Evangelopoulos D, Guzman JD, Gibbons S, Keep NH, et al. Characterisation of ATP-dependent Mur ligases involved in the biogenesis of cell wall peptidoglycan in Mycobacterium tuberculosis. PLoS One 2013; 8:e60143; http://dx.doi.org/10.1371/journal.pone.0060143; PMID: 23555903
   PubMed Web of Science ®Google Scholar
• Vilaplana C, Marzo E, Tapia G, Diaz J, Garcia V, Cardona P-J. Ibuprofen is able to reduce the lung pathology, to decrease bacillary load in tissues and to increase survival in a new murine experimental model of active tuberculosis. J Infect Dis 2013; 208:199 - 202; http://dx.doi.org/10.1093/infdis/jit152; PMID: 23564636
   PubMed Web of Science ®Google Scholar
• Dooley KE, Mitnick CD, Ann DeGroote M, Obuku E, Belitsky V, Hamilton CD, et al, Efficacy Subgroup, RESIST-TB. Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis. Clin Infect Dis 2012; 55:572 - 81; http://dx.doi.org/10.1093/cid/cis487; PMID: 22615332
   PubMed Web of Science ®Google Scholar
• Gler MT, Skripconoka V, Sanchez-Garavito E, Xiao H, Cabrera-Rivero JL, Vargas-Vasquez DE, et al. Delamanid for multidrug-resistant pulmonary tuberculosis. N Engl J Med 2012; 366:2151 - 60; http://dx.doi.org/10.1056/NEJMoa1112433; PMID: 22670901
   PubMed Web of Science ®Google Scholar
• Bhakta S, Besra GS, Upton AM, Parish T, Sholto-Douglas-Vernon C, Gibson KJ, et al. Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target. J Exp Med 2004; 199:1191 - 9; http://dx.doi.org/10.1084/jem.20031956; PMID: 15117974
   PubMed Web of Science ®Google Scholar
• Westwood IM, Bhakta S, Russell AJ, Fullam E, Anderton MC, Kawamura A, et al. Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars. Protein Cell 2010; 1:82 - 95; http://dx.doi.org/10.1007/s13238-010-0006-1; PMID: 21204000
   PubMed Web of Science ®Google Scholar
• Abuhammad A, Fullam E, Lowe ED, Staunton D, Kawamura A, Westwood IM, et al. Piperidinols that show anti-tubercular activity as inhibitors of arylamine N-acetyltransferase: an essential enzyme for mycobacterial survival inside macrophages. PLoS One 2012; 7:e52790; http://dx.doi.org/10.1371/journal.pone.0052790; PMID: 23285185
   PubMed Web of Science ®Google Scholar
• Batt SM, Jabeen T, Bhowruth V, Quill L, Lund PA, Eggeling L, et al. Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors. Proc Natl Acad Sci U S A 2012; 109:11354 - 9; http://dx.doi.org/10.1073/pnas.1205735109; PMID: 22733761
   PubMed Web of Science ®Google Scholar
• Hickey TB, Ziltener HJ, Speert DP, Stokes RW. Mycobacterium tuberculosis employs Cpn60.2 as an adhesin that binds CD43 on the macrophage surface. Cell Microbiol 2010; 12:1634 - 47; http://dx.doi.org/10.1111/j.1462-5822.2010.01496.x; PMID: 20633027
   PubMed Web of Science ®Google Scholar
• Henderson B, Pockley AG. Molecular chaperones and protein-folding catalysts as intercellular signaling regulators in immunity and inflammation. J Leukoc Biol 2010; 88:445 - 62; http://dx.doi.org/10.1189/jlb.1209779; PMID: 20445014
   PubMed Web of Science ®Google Scholar
• Wallis RS, Kim P, Cole S, Hanna D, Andrade BB, Maeurer M, et al. Tuberculosis biomarkers discovery: developments, needs, and challenges. Lancet Infect Dis 2013; 13:362 - 72; http://dx.doi.org/10.1016/S1473-3099(13)70034-3; PMID: 23531389
   PubMed Web of Science ®Google Scholar
• den Hertog AL, Mayboroda OA, Klatser PR, Anthony RM. Simple rapid near-patient diagnostics for tuberculosis remain elusive--is a “treat-to-test” strategy more realistic?. PLoS Pathog 2011; 7:e1002207; http://dx.doi.org/10.1371/journal.ppat.1002207; PMID: 22072958
   PubMed Web of Science ®Google Scholar